CARES:A Prospective, Phase IV, Open-Label, Non-Randomiozed, Multicenter, Surveillance REgistry Study to Evaluate the Safety of DEFINITY in Clinical Practice

ID Number 08-1284

Principal Investigator(s)
Martin E Goldman

Department(s) or Division(s)

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®. DEFINITY is a contrast agent that is used during echocardiogram measurements of the heart. Identifier: NCT00625365

Contact Information
Ida Guzman

Recruiting Patients: No